Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shaochuan Liu
Institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
Observed institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
ORCID:
0000-0002-4305-6173
Observed ORCID:
0000-0002-4305-6173
OpenAlex ID:
A5010685588
anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells
2020
·
Shaochuan Liu
, Tingting Qin
, et al.
·
Cell Death and Disease
·
201
PDF
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
2023
·
Shaochuan Liu
, Qian Sun
, et al.
·
Journal of Hematology & Oncology
·
114
PDF
Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer
2024
·
Junyi Li
, Yuanjie Cao
, et al.
·
Journal for ImmunoTherapy of Cancer
·
64
PDF
CD4+ T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancer
2022
·
Shaochuan Liu
, Yuan Meng
, et al.
·
Cell Death and Disease
·
56
PDF
Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling
2020
·
Tingting Qin
, Zhujun Liu
, et al.
·
Cancer Biology and Medicine
·
51
Effect of bevacizumab on the tight junction proteins of vascular endothelial cells.
2019
·
Yanan Jia
, Tingting Qin
, et al.
·
PubMed
·
26
Immune‐independent acquired resistance to PD‐L1 antibody initiated by PD‐L1 upregulation via PI3K / AKT signaling can be reversed by anlotinib
2023
·
Yuan Gao
, Yingfang Feng
, et al.
·
Cancer Medicine
·
20
PDF
PD-L1 Expression Is Associated With VEGFA and LADC Patients' Survival
2019
·
Shaochuan Liu
, Tingting Qin
, et al.
·
Frontiers in Oncology
·
18
PDF
CK2B Induces CD8+ T‐Cell Exhaustion through HDAC8‐Mediated Epigenetic Reprogramming to Limit the Efficacy of Anti‐PD‐1 Therapy in Non‐Small‐Cell Lung Cancer
2025
·
Shaochuan Liu
, Shiya Ma
, et al.
·
Advanced Science
·
15
PDF
Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma
2021
·
Baihui Li
, Ziqi Huang
, et al.
·
Neoplasia
·
15
PDF
Rational pemetrexed combined with CIK therapy plus anti-PD-1 mAbs administration sequence will effectively promote the efficacy of CIK therapy in non-small cell lung cancer
2022
·
Shaochuan Liu
, Yuan Meng
, et al.
·
Cancer Gene Therapy
·
10
Clinical importance of VEGFC and PD‐L1 co‐expression in lung adenocarcinoma patients
2020
·
Tingting Qin
, Junling Xia
, et al.
·
Thoracic Cancer
·
10
PDF
Phosphoglycerate mutase 1 promotes breast cancer progression through inducing immunosuppressive M2 macrophages
2024
·
Dong Zhang
, Min Wang
, et al.
·
Cancer Gene Therapy
·
9
Anlotinib Downregulates RGC32 Which Provoked by Bevacizumab
2022
·
Zhujun Liu
, Tingting Qin
, et al.
·
Frontiers in Oncology
·
8
Anlotinib and anti-PD-1 mAbs perfected CIK cell therapy for lung adenocarcinoma in preclinical trials
2024
·
Yingge Lv
, Hua Zhao
, et al.
·
Journal of Leukocyte Biology
·
5
PDF
A senescence-associated gene signature predicts radiotherapy prognosis in non-small cell lung cancer and identifies CSF1 as a target to potentiate radioimmunotherapy
2026
·
Shaochuan Liu
, Yuhan Zhang
, et al.
·
Biology Direct
·
1
PD-L1 expression in microvascular endothelial cells predicts the efficacy and side effects of anlotinib
2025
·
Yingfang Feng
, Yuan Gao
, et al.
·
Frontiers in Oncology
·
1
Immunosenescence in radio-immunotherapy: From biological mechanisms to therapeutic opportunities?
2026
·
Shaochuan Liu
, Liuze Li
, et al.
·
Ageing Research Reviews
Changes in PD-L1 expression on microvessel endothelial cells during melanoma tumor growth and the regulation by anlotinib
2023
·
Yingfang Feng
, Yuan Gao
, et al.
·
Research Square
PDF
Shift of tumor-infiltrating immune cells after adding immune checkpoint inhibitors to neoadjuvant chemotherapy against NSCLC.
2022
·
Yulin Ren
, Zhenzhen Hui
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
20
Citation count:
624
H-index:
10
I10-index:
12
Year
Topic
Type